4
MARKET OVERVIEW
Radiotherapy market growth driven by AI, government investments, and emerging market opportunities amid cost challenges.
42
4.2.1.1
ADVANCEMENTS IN RADIOTHERAPY TREATMENT
4.2.1.2
AI AND AUTOMATION IN TREATMENT PLANNING
4.2.1.3
INCREASING GOVERNMENT INVESTMENTS AND AWARENESS INITIATIVES FOR CANCER CARE
4.2.2.1
HIGH COSTS ASSOCIATED WITH RADIOTHERAPY SYSTEMS SUCH AS PROTON THERAPY AND ADVANCED LINEAR ACCELERATORS
4.2.2.2
LIMITED ACCESS TO ADVANCED RADIOTHERAPY INFRASTRUCTURE AND SKILLED WORKFORCE IN LOW- AND MIDDLE-INCOME COUNTRIES
4.2.2.3
SHORTAGE OF SKILLED RADIATION ONCOLOGISTS, MEDICAL PHYSICISTS, AND TRAINED TECHNICIANS
4.2.3.1
EMERGING MARKETS OFFER SIGNIFICANT GROWTH POTENTIAL FOR RADIOTHERAPY TECHNOLOGIES
4.2.3.2
INTEGRATION OF RADIOTHERAPY WITH IMMUNOTHERAPY AND SYSTEMIC THERAPIES
4.2.3.3
GROWING ADOPTION OF OUTPATIENT RADIOTHERAPY AND HYPOFRACTIONATED TREATMENT REGIMENS
4.2.4.1
INCREASING CYBERSECURITY AND DATA PROTECTION CHALLENGES IN DIGITAL RADIOTHERAPY ECOSYSTEMS
4.2.4.2
PATIENT SAFETY CONCERNS AND RADIATION EXPOSURE RISKS
4.4
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Navigate competitive forces and macroeconomic shifts to capitalize on radiotherapy market opportunities.
54
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
INTENSITY OF COMPETITIVE RIVALRY
5.1.2
BARGAINING POWER OF SUPPLIERS
5.1.3
BARGAINING POWER OF BUYERS
5.1.4
THREAT OF SUBSTITUTES
5.1.5
THREAT OF NEW ENTRANTS
5.2
MACROECONOMIC OUTLOOK
5.2.1
GDP TRENDS AND FORECAST
5.2.2
TRENDS IN GLOBAL RADIOTHERAPY INDUSTRY
5.3.1
RESEARCH & DEVELOPMENT
5.3.2
PROCUREMENT & MANUFACTURING
5.3.3
MARKETING, SALES, AND DISTRIBUTION
5.5.1
AVERAGE SELLING PRICE TREND, BY REGION
5.6.1
IMPORT DATA (HS CODE 902214)
5.6.2
EXPORT DATA (HS CODE 902214)
5.7
KEY CONFERENCES & EVENTS, 2026–2027
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.9
INVESTMENT & FUNDING SCENARIO
5.10.1
SBRT’S ROLE IN MINIMIZING RADIATION RISK IN ELDERLY PATIENTS
5.10.2
RADIOTHERAPY FOR BREAST CANCER IN PATIENTS WITH HEREDITARY COPROPORPHYRIA
5.10.3
RADIATION THERAPY TREATMENT FOR TRANSITIONAL CELL CARCINOMA OF DISTAL URETHRA
5.11
IMPACT OF 2025 US TARIFF - RADIOTHERAPY MARKET
5.11.2
PRICE IMPACT ANALYSIS
5.11.3
IMPACT ON COUNTRIES/REGIONS
5.11.4
IMPACT ON END-USE INDUSTRIES
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
AI-driven innovations revolutionize radiotherapy with adaptive planning, cloud platforms, and patent growth.
72
6.1.1
MR-GUIDED ADAPTIVE RADIOTHERAPY
6.1.2
ARTIFICIAL INTELLIGENCE-DRIVEN TREATMENT PLANNING
6.1.3
PROTON AND PARTICLE THERAPY
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.1
ADVANCED TREATMENT PLANNING SYSTEMS AND AI-ENABLED DECISION SUPPORT
6.2.2
CLOUD-BASED AND REMOTE RADIOTHERAPY PLATFORMS
6.3.1
INNOVATIONS AND PATENT REGISTRATIONS
6.5
IMPACT OF AI/GEN AI ON RADIOTHERAPY MARKET
6.5.1
TOP USE CASES AND MARKET POTENTIAL
6.5.2
BEST PRACTICES FOLLOWED BY MANUFACTURERS IN RADIOTHERAPY MARKET
6.5.3
CASE STUDIES RELATED TO AI IMPLEMENTATION IN RADIOTHERAPY MARKET
6.5.4
INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.5.5
CLIENT'S READINESS TO ADOPT GENERATIVE AI IN RADIOTHERAPY MARKET
6.6
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
7
REGULATORY LANDSCAPE
Navigate complex global regulations with insights on key regional compliance and approval processes.
84
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Discover unmet needs and stakeholder influence shaping radiotherapy system purchases.
91
8.1
DECISION-MAKING PROCESS
8.2
KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
8.3
ADOPTION BARRIERS AND INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM END-USERS
9
RADIOTHERAPY MARKET, BY SYSTEM AND SOFTWARE & SERVICE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 3 Data Tables
95
9.2.1
INCREASING ADOPTION OF AI-ENABLED AND IMAGE-GUIDED RADIOTHERAPY SYSTEMS TO DRIVE GROWTH
9.3.1
INCREASING ADOPTION OF INTEGRATED ONCOLOGY SOFTWARE PLATFORMS TO SUPPORT MARKET GROWTH
10
RADIOTHERAPY MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 17 Data Tables
99
10.2
EXTERNAL BEAM RADIOTHERAPY
10.2.1.1
HIGH INCIDENCE RATE AND EFFICIENCY OF EBRT IN PROSTATE CANCER TREATMENT TO SUPPORT GROWTH
10.2.2.1
THERAPEUTIC BENEFITS OF EBRT TO DRIVE MARKET
10.2.3.1
HIGH PREVALENCE OF LUNG CANCER AND EFFICIENCY OF EBRT TO DRIVE MARKET
10.2.4
HEAD & NECK CANCER
10.2.4.1
INCREASING PREFERENCE FOR NONINVASIVE TREATMENT OF HEAD & NECK CANCERS TO DRIVE MARKET
10.2.5.1
HIGH INCIDENCE OF COLORECTAL CANCER TO SUPPORT MARKET GROWTH
10.2.6
OTHER EBRT APPLICATIONS
10.3
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
10.3.1.1
PRECISION OF BRACHYTHERAPY TO DRIVE MARKET
10.3.2
GYNECOLOGICAL CANCER
10.3.2.1
AVAILABILITY OF ALTERNATIVES TO HINDER ADOPTION OF BRACHYTHERAPY
10.3.3.1
GROWING ADOPTION OF ACCELERATED PARTIAL BREAST IRRADIATION DRIVES BREAST BRACHYTHERAPY UTILIZATION
10.3.4.1
MRI-GUIDED ADAPTIVE BRACHYTHERAPY AND AI-ENABLED PLANNING DRIVE ADVANCES IN CERVICAL CANCER TREATMENT
10.3.5.1
INCREASING AWARENESS OF ORGAN-PRESERVATION STRATEGIES TO DRIVE MARKET
10.3.6
OTHER IBRT APPLICATIONS
11
RADIOTHERAPY MARKET, BY PROCEDURE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 14 Data Tables
114
11.2
EXTERNAL BEAM RADIOTHERAPY
11.2.1
IMAGE-GUIDED RADIOTHERAPY
11.2.1.1
GROWING ADOPTION OF REAL-TIME IMAGING AND ADAPTIVE WORKFLOWS TO SUPPORT MARKET GROWTH
11.2.2
INTENSITY-MODULATED RADIOTHERAPY
11.2.2.1
GROWING ADOPTION OF HYPOFRACTIONATION AND ADAPTIVE TREATMENT PLANNING TO PROPEL MARKET
11.2.3.1
ADVANCEMENTS IN TREATMENT PLANNING SYSTEMS AND EXPANSION OF PROTON THERAPY FACILITIES TO DRIVE ADOPTION
11.2.4
3D CONFORMAL RADIOTHERAPY
11.2.4.1
CONTINUED UTILIZATION IN RESOURCE-CONSTRAINED SETTINGS TO SUPPORT ADOPTION OF 3D-CRT
11.2.5
STEREOTACTIC RADIOTHERAPY
11.2.5.1
EXPANDING CLINICAL APPLICATIONS AND HYPOFRACTIONATED TREATMENT APPROACHES TO PROPEL ADOPTION
11.2.6
OTHER EBRT PROCEDURES
11.3
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
11.3.1.1
LOW RISK OF RADIATION EXPOSURE TO SURROUNDING TISSUES TO DRIVE ADOPTION
11.3.2.1
ADVANCEMENTS IN IMAGE-GUIDED PLANNING AND DOSE OPTIMIZATION TO DRIVE GROWTH
11.3.3.1
BETTER RADIATION SAFETY, EASIER PROSPECTIVE PLANNING, AND PRECISE DOSE SHAPING TO DRIVE ADOPTION
12
RADIOTHERAPY MARKET, BY TECHNOLOGY
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 24 Data Tables
127
12.2
EXTERNAL BEAM RADIOTHERAPY
12.2.1.1
CONVENTIONAL LINACS
12.2.1.1.1
LONG TREATMENT DURATION TO LIMIT ADOPTION
12.2.1.2
STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS
12.2.1.3.1
REAL-TIME IMAGING ADVANTAGE TO PROPEL GROWTH
12.2.2.1.1
ENHANCED OUTCOMES AND OTHER ADVANTAGES TO BOOST ADOPTION
12.2.2.2.1
INCREASING INVESTMENTS IN SYNCHROTRON FACILITIES TO DRIVE MARKET
12.2.2.3
SYNCHROCYCLOTRONS
12.2.2.3.1
COMPACT SYNCHROCYCLOTRON INNOVATIONS SUPPORT ADOPTION DESPITE INFRASTRUCTURE CHALLENGES
12.2.3
CONVENTIONAL COBALT-60 TELETHERAPY
12.2.3.1
COMPLEX DOSE DELIVERY PLANNING AND RADIATION EXPOSURE TO LIMIT MARKET ADOPTION
12.3
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
12.3.1.1
ADVERSE EFFECTS ASSOCIATED WITH BRACHYTHERAPY SEEDS TO LIMIT ADOPTION
12.3.2.1
PROPER POSITIONING AND BETTER CONTROL OF ISOTOPES IN MODERN AFTERLOADERS TO DRIVE DEMAND
12.3.3.1
GROWING CLINICAL EVIDENCE SUPPORTING LONG-TERM EFFICACY TO DRIVE ADOPTION
12.3.4.1
HIGH RISK OF RADIATION EXPOSURE IN MANUAL APPLICATORS TO LIMIT GROWTH
13
RADIOTHERAPY MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 3 Data Tables
148
13.2.1
INCREASING ADOPTION OF AI-ENABLED AND PRECISION RADIATION THERAPY SOLUTIONS TO DRIVE MARKET
13.3
INDEPENDENT RADIOTHERAPY CENTERS
13.3.1
EXPANSION OF RADIOTHERAPY INFRASTRUCTURE AND COMMUNITY-BASED CANCER CARE TO PROPEL MARKET
14
RADIOTHERAPY MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 14 Countries | 142 Data Tables.
152
14.2.1.1
FAVORABLE REIMBURSEMENT SCENARIO TO DRIVE GROWTH
14.2.2.1
FAVORABLE INITIATIVES FROM GOVERNMENT AND PRIVATE ORGANIZATIONS TO BOOST MARKET
14.3.1.1
AVAILABILITY OF NOVEL RADIOTHERAPY PRODUCTS TO DRIVE MARKET
14.3.2.1
PRESENCE OF ADVANCED HEALTHCARE SYSTEMS TO AUGMENT GROWTH
14.3.3.1
GROWING ADOPTION OF ADVANCED RADIOTHERAPY TECHNOLOGIES AND RISING CANCER BURDEN TO DRIVE MARKET
14.3.4.1
ADOPTION OF ADVANCED RADIOTHERAPY TECHNOLOGIES TO DRIVE MARKET
14.3.5.1
RISING ADOPTION OF ADVANCED RADIOTHERAPY TECHNOLOGIES AND STRONG RESEARCH ECOSYSTEM TO SUPPORT MARKET GROWTH
14.4.1.1
FAVORABLE REIMBURSEMENT POLICIES TO PROPEL MARKET
14.4.2.1
PRECISION ONCOLOGY INVESTMENTS TO DRIVE MARKET
14.4.3.1
GROWING CANCER BURDEN, INFRASTRUCTURE INVESTMENTS, AND ADVANCED TECHNOLOGY ADOPTION TO DRIVE MARKET
14.4.4.1
RISING INVESTMENTS IN HEAVY-ION THERAPY INFRASTRUCTURE TO PROPEL MARKET
14.4.5.1
GROWING CANCER CASES TO FUEL MARKET
14.4.6
REST OF ASIA PACIFIC
14.5.1.1
INCREASING PREVALENCE OF CANCER TO FUEL MARKET
14.5.2.1
EXPANDING ONCOLOGY INFRASTRUCTURE AND PRECISION RADIOTHERAPY ADOPTION TO DRIVE GROWTH
14.5.3
REST OF LATIN AMERICA
14.6
MIDDLE EAST & AFRICA
14.6.1.1
INCREASING INVESTMENTS IN ADVANCED ONCOLOGY INFRASTRUCTURE TO PROPEL MARKET
14.6.2
REST OF MIDDLE EAST & AFRICA
15
COMPETITIVE LANDSCAPE
Discover top strategies and market leaders shaping the radiotherapy competitive landscape.
220
15.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
15.2.1
KEY PLAYER COMPETITIVE STRATEGIES IN RADIOTHERAPY MARKET, JANUARY 2022–MAY 2026
15.3
REVENUE ANALYSIS, 2021–2025
15.4
MARKET SHARE ANALYSIS, 2025
15.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
15.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
15.5.5.1
COMPANY FOOTPRINT
15.5.5.2
REGION FOOTPRINT
15.5.5.3
TECHNOLOGY FOOTPRINT
15.5.5.4
APPLICATION FOOTPRINT
15.5.5.5
END-USER FOOTPRINT
15.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
15.6.1
PROGRESSIVE COMPANIES
15.6.2
RESPONSIVE COMPANIES
15.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
15.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES, 2025
15.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2025
15.7
COMPANY VALUATION & FINANCIAL METRICS
15.9
COMPETITIVE SCENARIO
15.9.1
PRODUCT LAUNCHES & APPROVALS
16
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
242
16.1.1
SIEMENS HEALTHINEERS AG
16.1.1.1
BUSINESS OVERVIEW
16.1.1.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
16.1.1.3
RECENT DEVELOPMENTS
16.1.1.3.1
PRODUCT APPROVALS
16.1.1.4.2
STRATEGIC CHOICES
16.1.1.4.3
WEAKNESSES & COMPETITIVE THREATS
16.1.3
ACCURAY INCORPORATED
16.1.5
VIEWRAY SYSTEMS, INC.
16.1.6
GT MEDICAL TECHNOLOGIES, INC.
16.1.7
HITACHI HIGH-TECH CORPORATION
16.1.8
SUMITOMO HEAVY INDUSTRIES, LTD.
16.1.10
MIM SOFTWARE INC.
16.1.11
PANACEA MEDICAL TECHNOLOGIES PVT. LTD.
16.1.12
PROVISION HEALTHCARE
16.1.13
MEVION MEDICAL SYSTEMS
16.1.14
KONINKLIJKE PHILIPS N.V.
16.2.1
SHINVA MEDICAL INSTRUMENT CO., LTD.
16.2.3
RAYSEARCH LABORATORIES
16.2.4
INTRAOP MEDICAL, INC.
16.2.5
OPTIVUS PROTON THERAPY, INC.
16.2.8
THERAGENICS CORPORATION
16.2.9
PROTOM INTERNATIONAL
16.2.12
MAGNETTX ONCOLOGY SOLUTIONS LTD.
17
RESEARCH METHODOLOGY
301
17.1.1.1
OBJECTIVES OF SECONDARY RESEARCH
17.1.1.2
LIST OF SECONDARY SOURCES
17.1.2.1
KEY DATA FROM PRIMARY SOURCES
17.1.2.2
KEY INDUSTRY INSIGHTS
17.2
MARKET ESTIMATION METHODOLOGY
17.2.1
BOTTOM-UP APPROACH
17.2.2
REVENUE MAPPING-BASED MARKET ESTIMATION
17.2.3
USAGE-BASED MARKET ESTIMATION
17.2.4
PRIMARY RESEARCH VALIDATION
17.3
DATA TRIANGULATION AND MARKET BREAKDOWN
17.4
MARKET SHARE ASSESSMENT
17.5
RESEARCH ASSUMPTIONS
17.6
RESEARCH LIMITATIONS
17.7.1
RISK ASSESSMENT ANALYSIS
18.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
18.3
CUSTOMIZATION OPTIONS
TABLE 1
RADIOTHERAPY MARKET: INCLUSION/EXCLUSION DETAILS
TABLE 2
DIFFERENT TYPES OF EXTERNAL BEAM RADIATION THERAPY (EBRT) TECHNIQUES AND ASSOCIATED ADVANTAGES AND DISADVANTAGES
TABLE 3
TREATMENT-RELATED EFFECTS AND TOXICITY CONCERNS
TABLE 4
RADIOTHERAPY MARKET: CURRENT UNMET NEEDS
TABLE 5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
TABLE 6
RADIOTHERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 7
AVERAGE SELLING PRICE TREND OF RADIOTHERAPY SYSTEMS, BY REGION, 2023–2025
TABLE 8
IMPORT DATA FOR HS CODE 902214-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD)
TABLE 9
EXPORT DATA FOR HS CODE 902214-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD)
TABLE 10
RADIOTHERAPY MARKET: KEY CONFERENCES & EVENTS, 2026–2027
TABLE 11
US-ADJUSTED RECIPROCAL TARIFF RATES IN MEDTECH INDUSTRY
TABLE 12
TARIFF-INDUCED PRICE INCREASES FOR HEALTHCARE PRODUCTS
TABLE 13
RADIOTHERAPY MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2020–2026
TABLE 14
KEY CLINICAL TRIALS EVALUATING ARTIFICIAL INTELLIGENCE IN RADIOTHERAPY
TABLE 15
KEY AI USE CASES AND MARKET POTENTIAL IN RADIOTHERAPY MARKET
TABLE 16
KEY CLINICAL CASE STUDIES OF ARTIFICIAL INTELLIGENCE APPLICATIONS IN RADIOTHERAPY
TABLE 17
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21
MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22
US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 23
CLASS II PRESCRIBED EQUIPMENT CERTIFICATES
TABLE 24
JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
TABLE 25
INDIA: MEDICAL DEVICE CLASSIFICATION UNDER CDSCO
TABLE 26
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RADIOTHERAPY SYSTEMS
TABLE 27
KEY BUYING CRITERIA FOR RADIOTHERAPY SYSTEMS
TABLE 28
RADIOTHERAPY MARKET: CURRENT UNMET NEEDS
TABLE 29
RADIOTHERAPY MARKET, BY SYSTEM AND SOFTWARE & SERVICE 2024–2031 (USD MILLION)
TABLE 30
RADIOTHERAPY SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 31
RADIOTHERAPY SOFTWARE & SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 32
RADIOTHERAPY MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 33
EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 34
EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 35
EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET FOR PROSTATE CANCER, BY REGION, 2024–2031 (USD MILLION)
TABLE 36
EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET FOR BREAST CANCER, BY REGION, 2024–2031 (USD MILLION)
TABLE 37
EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET FOR LUNG CANCER, BY REGION, 2024–2031 (USD MILLION)
TABLE 38
EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET FOR HEAD & NECK CANCER, BY REGION, 2024–2031 (USD MILLION)
TABLE 39
EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET FOR COLORECTAL CANCER, BY REGION, 2024–2031 (USD MILLION)
TABLE 40
OTHER EBRT APPLICATIONS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 41
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 42
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 43
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR PROSTATE CANCER, BY REGION, 2024–2031 (USD MILLION)
TABLE 44
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR GYNECOLOGICAL CANCER, BY REGION, 2024–2031 (USD MILLION)
TABLE 45
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR BREAST CANCER, BY REGION, 2024–2031 (USD MILLION)
TABLE 46
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR CERVICAL CANCER, BY REGION, 2024–2031 (USD MILLION)
TABLE 47
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR PENILE CANCER, BY REGION, 2024–2031 (USD MILLION)
TABLE 48
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR OTHER IBRT APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 49
RADIOTHERAPY MARKET, BY PROCEDURE, 2024–2031 (USD MILLION)
TABLE 50
EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 51
EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 52
IMAGE-GUIDED RADIOTHERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 53
INTENSITY-MODULATED RADIOTHERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 54
PARTICLE THERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 55
3D CONFORMAL RADIOTHERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 56
STEREOTACTIC RADIOTHERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 57
OTHER EBRT PROCEDURES MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 58
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 59
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 60
LDR BRACHYTHERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 61
HDR BRACHYTHERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 62
PDR BRACHYTHERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 63
RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 64
EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 65
EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 66
LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 67
LINACS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 68
CONVENTIONAL LINACS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 69
STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 70
STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 71
CYBERKNIFE MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 72
GAMMA KNIFE MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 73
TOMOTHERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 74
MRI LINACS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 75
PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2024–2031 (USD MILLION)
TABLE 76
PARTICLE THERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 77
CYCLOTRONS THERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 78
SYNCHROTRONS THERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 79
SYNCHROCYCLOTRONS THERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 80
CONVENTIONAL COBALT-60 TELETHERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 81
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 82
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 83
SEEDS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 84
AFTERLOADERS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 85
IORT SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 86
APPLICATORS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 87
RADIOTHERAPY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 88
RADIOTHERAPY MARKET FOR HOSPITALS, BY REGION, 2024–2031 (USD MILLION)
TABLE 89
RADIOTHERAPY MARKET FOR INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 90
RADIOTHERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 91
NORTH AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 92
NORTH AMERICA: RADIOTHERAPY MARKET, BY SYSTEM AND SOFTWARE & SERVICE, 2024–2031 (USD MILLION)
TABLE 93
NORTH AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 94
NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 95
NORTH AMERICA: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 96
NORTH AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 97
NORTH AMERICA: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2024–2031 (USD MILLION)
TABLE 98
NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 99
NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 100
NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 101
NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 102
NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 103
NORTH AMERICA: RADIOTHERAPY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 104
US: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 105
US: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 106
US: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 107
US: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 108
CANADA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 109
CANADA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 110
CANADA: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 111
CANADA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 112
EUROPE: RADIOTHERAPY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 113
EUROPE: RADIOTHERAPY MARKET, BY SYSTEM AND SOFTWARE & SERVICE, 2024–2031 (USD MILLION)
TABLE 114
EUROPE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 115
EUROPE: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 116
EUROPE: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 117
EUROPE: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 118
EUROPE: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2024–2031 (USD MILLION)
TABLE 119
EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 120
EUROPE: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 121
EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 122
EUROPE: EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 123
EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 124
EUROPE: RADIOTHERAPY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 125
GERMANY: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 126
GERMANY: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 127
GERMANY: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 128
GERMANY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 129
FRANCE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 130
FRANCE: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 131
FRANCE: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 132
FRANCE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 133
UK: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 134
UK: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 135
UK: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 136
UK: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 137
SPAIN: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 138
SPAIN: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 139
SPAIN: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 140
SPAIN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 141
ITALY: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 142
ITALY: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 143
ITALY: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 144
ITALY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 145
REST OF EUROPE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 146
REST OF EUROPE: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 147
REST OF EUROPE: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 148
REST OF EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 149
ASIA PACIFIC: RADIOTHERAPY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 150
ASIA PACIFIC: RADIOTHERAPY MARKET, BY SYSTEM AND SOFTWARE & SERVICE, 2024–2031 (USD MILLION)
TABLE 151
ASIA PACIFIC: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 152
ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 153
ASIA PACIFIC: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 154
ASIA PACIFIC: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 155
ASIA PACIFIC: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2024–2031 (USD MILLION)
TABLE 156
ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 157
ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 158
ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 159
ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 160
ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 161
ASIA PACIFIC: RADIOTHERAPY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 162
JAPAN: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 163
JAPAN: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 164
JAPAN: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 165
JAPAN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 166
CHINA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 167
CHINA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 168
CHINA: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 169
CHINA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 170
INDIA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 171
INDIA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 172
INDIA: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 173
INDIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 174
SOUTH KOREA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 175
SOUTH KOREA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 176
SOUTH KOREA: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 177
SOUTH KOREA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 178
AUSTRALIA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 179
AUSTRALIA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 180
AUSTRALIA: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 181
AUSTRALIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 182
REST OF ASIA PACIFIC: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 183
REST OF ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 184
REST OF ASIA PACIFIC: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 185
REST OF ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 186
LATIN AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 187
LATIN AMERICA: RADIOTHERAPY MARKET, BY SYSTEM AND SOFTWARE & SERVICE, 2024–2031 (USD MILLION)
TABLE 188
LATIN AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 189
LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 190
LATIN AMERICA: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 191
LATIN AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 192
LATIN AMERICA: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2024–2031 (USD MILLION)
TABLE 193
LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 194
LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 195
LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 196
LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 197
LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 198
LATIN AMERICA: RADIOTHERAPY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 199
BRAZIL: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 200
BRAZIL: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 201
BRAZIL: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 202
BRAZIL: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 203
MEXICO: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 204
MEXICO: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 205
MEXICO: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 206
MEXICO: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 207
REST OF LATIN AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 208
REST OF LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 209
REST OF LATIN AMERICA: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 210
REST OF LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 211
MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 212
MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY SYSTEM AND SOFTWARE & SERVICE, 2024–2031 (USD MILLION)
TABLE 213
MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 214
MIDDLE EAST & AFRICA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 215
MIDDLE EAST & AFRICA: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 216
MIDDLE EAST & AFRICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 217
MIDDLE EAST & AFRICA: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2024–2031 (USD MILLION)
TABLE 218
MIDDLE EAST & AFRICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 219
MIDDLE EAST & AFRICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 220
MIDDLE EAST & AFRICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 221
MIDDLE EAST & AFRICA: EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 222
MIDDLE EAST & AFRICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 223
MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 224
GCC COUNTRIES: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 225
GCC COUNTRIES: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 226
GCC COUNTRIES: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 227
GCC COUNTRIES: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 228
REST OF MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 229
REST OF MIDDLE EAST & AFRICA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 230
REST OF MIDDLE EAST & AFRICA: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 231
REST OF MIDDLE EAST & AFRICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 232
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN RADIOTHERAPY MARKET, JANUARY 2022–MAY 2026
TABLE 233
RADIOTHERAPY MARKET: DEGREE OF COMPETITION
TABLE 234
RADIOTHERAPY MARKET: REGION FOOTPRINT
TABLE 235
RADIOTHERAPY MARKET: TECHNOLOGY FOOTPRINT
TABLE 236
RADIOTHERAPY MARKET: APPLICATION FOOTPRINT
TABLE 237
RADIOTHERAPY MARKET: END-USER FOOTPRINT
TABLE 238
RADIOTHERAPY MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 239
RADIOTHERAPY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 240
RADIOTHERAPY MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2026
TABLE 241
RADIOTHERAPY MARKET: DEALS, JANUARY 2022–MAY 2026
TABLE 242
RADIOTHERAPY MARKET: EXPANSIONS, JANUARY 2022–MAY 2026
TABLE 243
SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
TABLE 244
SIEMENS HEALTHINEERS AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 245
SIEMENS HEALTHINEERS AG: PRODUCT APPROVALS, JANUARY 2022–MAY 2026
TABLE 246
SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022−MAY 2026
TABLE 247
ELEKTA: COMPANY OVERVIEW
TABLE 248
ELEKTA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 249
ELEKTA: PRODUCTS LAUNCHES & APPROVALS, JANUARY 2022−MAY 2026
TABLE 250
ELEKTA: DEALS, JANUARY 2022−MAY 2026
TABLE 251
ELEKTA: EXPANSIONS, JANUARY 2022−MAY 2026
TABLE 252
ACCURAY INCORPORATED: COMPANY OVERVIEW
TABLE 253
ACCURAY INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 254
ACCURAY INCORPORATED: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022−MAY 2026
TABLE 255
ACCURAY INCORPORATED: DEALS, JANUARY 2022−MAY 2026
TABLE 256
ACCURAY INCORPORATED: EXPANSIONS, JANUARY 2022−MAY 2026
TABLE 257
IBA WORLDWIDE: COMPANY OVERVIEW
TABLE 258
IBA WORLDWIDE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 259
IBA WORLDWIDE: PRODUCT LAUNCHES, JANUARY 2022−MAY 2026
TABLE 260
IBA WORLDWIDE: DEALS, JANUARY 2022−MAY 2026
TABLE 261
VIEWRAY SYSTEMS, INC.: COMPANY OVERVIEW
TABLE 262
VIEWRAY SYSTEMS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 263
VIEWRAY SYSTEMS, INC.: PRODUCT APPROVALS, JANUARY 2022−MAY 2026
TABLE 264
VIEWRAY SYSTEMS, INC.: DEALS, JANUARY 2022−MAY 2026
TABLE 265
GT MEDICAL TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 266
GT MEDICAL TECHNOLOGIES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 267
HITACHI HIGH-TECH CORPORATION: COMPANY OVERVIEW
TABLE 268
HITACHI HIGH-TECH CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 269
HITACHI HIGH-TECH CORPORATION: DEALS, JANUARY 2022−MAY 2026
TABLE 270
SUMITOMO HEAVY INDUSTRIES, LTD.: COMPANY OVERVIEW
TABLE 271
SUMITOMO HEAVY INDUSTRIES, LTD.: PRODUCTS/SOLUTIONS/ SERVICES OFFERED
TABLE 272
ZEISS GROUP : COMPANY OVERVIEW
TABLE 273
ZEISS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 274
ZEISS GROUP: PRODUCT LAUNCHES, JANUARY 2022−MAY 2026
TABLE 275
MIM SOFTWARE INC.: COMPANY OVERVIEW
TABLE 276
MIM SOFTWARE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 277
MIM SOFTWARE INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022−MAY 2026
TABLE 278
MIM SOFTWARE INC.: DEALS, JANUARY 2022−MAY 2026
TABLE 279
PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: COMPANY OVERVIEW
TABLE 280
PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: PRODUCTS/SOLUTIONS/ SERVICES OFFERED
TABLE 281
PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: PRODUCT LAUNCHES , JANUARY 2022−MAY 2026
TABLE 282
PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: DEALS, JANUARY 2022−MAY 2026
TABLE 283
PROVISION HEALTHCARE: COMPANY OVERVIEW
TABLE 284
PROVISION HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 285
MEVION MEDICAL SYSTEMS: COMPANY OVERVIEW
TABLE 286
MEVION MEDICAL SYSTEMS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 287
MEVION MEDICAL SYSTEMS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022−MAY 2026
TABLE 288
MEVION MEDICAL SYSTEMS: DEALS, JANUARY 2022−MAY 2026
TABLE 289
KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
TABLE 290
KONINKLIJKE PHILIPS N.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 291
KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES, JANUARY 2022−MAY 2026
TABLE 292
SHINVA MEDICAL INSTRUMENT CO., LTD.: COMPANY OVERVIEW
TABLE 293
BRAINLAB AG: COMPANY OVERVIEW
TABLE 294
RAYSEARCH LABORATORIES: COMPANY OVERVIEW
TABLE 295
INTRAOP MEDICAL, INC.: COMPANY OVERVIEW
TABLE 296
OPTIVUS PROTON THERAPY, INC.: COMPANY OVERVIEW
TABLE 297
BEBIG MEDICAL: COMPANY OVERVIEW
TABLE 298
P-CURE: COMPANY OVERVIEW
TABLE 299
THERAGENICS CORPORATION: COMPANY OVERVIEW
TABLE 300
PROTOM INTERNATIONAL: COMPANY OVERVIEW
TABLE 301
DOSISOFT SA: COMPANY OVERVIEW
TABLE 302
ISOAID, LLC: COMPANY OVERVIEW
TABLE 303
MAGNETTX ONCOLOGY SOLUTIONS LTD.: COMPANY OVERVIEW
TABLE 304
RADIOTHERAPY MARKET: RESEARCH ASSUMPTIONS
FIGURE 1
RADIOTHERAPY MARKET SEGMENTATION AND REGIONAL SCOPE
FIGURE 2
DURATION COVERED
FIGURE 4
GLOBAL RADIOTHERAPY MARKET, 2024–2031
FIGURE 5
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN RADIOTHERAPY MARKET, 2022–2026
FIGURE 6
DISRUPTIONS INFLUENCING GROWTH OF RADIOTHERAPY MARKET
FIGURE 7
HIGH-GROWTH SEGMENTS IN RADIOTHERAPY MARKET, 2026–2031
FIGURE 8
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN RADIOTHERAPY MARKET DURING FORECAST PERIOD
FIGURE 9
ADVANCEMENTS IN AI AND ADAPTIVE RADIOTHERAPY ENHANCE TREATMENT PRECISION
FIGURE 10
NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET SHARE DURING STUDY PERIOD
FIGURE 11
EXTERNAL BEAM RADIATION THERAPY SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2025
FIGURE 12
CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 13
RADIOTHERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 14
RADIOTHERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 15
RADIOTHERAPY MARKET: VALUE CHAIN ANALYSIS
FIGURE 16
RADIOTHERAPY MARKET: ECOSYSTEM ANALYSIS
FIGURE 17
AVERAGE SELLING PRICE TREND OF RADIOTHERAPY SYSTEMS, BY REGION, 2023–2025 (USD)
FIGURE 18
IMPORT DATA FOR HS CODE 902214-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025
FIGURE 19
EXPORT DATA FOR HS CODE 902214-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025
FIGURE 20
RADIOTHERAPY MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 21
RADIOTHERAPY MARKET: INVESTMENT & FUNDING SCENARIO, 2019–2023
FIGURE 22
RADIOTHERAPY MARKET: NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023
FIGURE 23
VALUE OF INVESTOR DEALS IN RADIOTHERAPY MARKET, BY KEY PLAYER, 2019–2023
FIGURE 24
PATENT ANALYSIS FOR RADIOTHERAPY MARKET, JANUARY 2016–DECEMBER 2025
FIGURE 25
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RADIOTHERAPY SYSTEMS
FIGURE 26
KEY BUYING CRITERIA FOR RADIOTHERAPY SYSTEMS
FIGURE 27
NORTH AMERICA: RADIOTHERAPY MARKET SNAPSHOT
FIGURE 28
ASIA PACIFIC: RADIOTHERAPY MARKET SNAPSHOT
FIGURE 29
REVENUE ANALYSIS OF KEY PLAYERS IN RADIOTHERAPY MARKET, 2021−2025
FIGURE 30
MARKET SHARE ANALYSIS OF KEY PLAYERS IN RADIOTHERAPY MARKET, 2025
FIGURE 31
RADIOTHERAPY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 32
RADIOTHERAPY MARKET: COMPANY FOOTPRINT
FIGURE 33
RADIOTHERAPY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 34
EV/EBITDA OF KEY VENDORS
FIGURE 35
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 36
RADIOTHERAPY MARKET: BRAND COMPARATIVE ANALYSIS
FIGURE 37
SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
FIGURE 38
ELEKTA: COMPANY SNAPSHOT
FIGURE 39
ACCURAY INCORPORATED: COMPANY SNAPSHOT
FIGURE 40
IBA WORLDWIDE: COMPANY SNAPSHOT
FIGURE 41
HITACHI HIGH-TECH CORPORATION: COMPANY SNAPSHOT
FIGURE 42
SUMITOMO HEAVY INDUSTRIES, LTD.: COMPANY SNAPSHOT
FIGURE 43
ZEISS GROUP: COMPANY SNAPSHOT
FIGURE 44
KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
FIGURE 45
RESEARCH DESIGN
FIGURE 46
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 47
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 48
RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 49
RADIOTHERAPY MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
FIGURE 50
MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2025)
FIGURE 51
RADIOTHERAPY MARKET: MARKET SIZE ESTIMATION METHODOLOGY
FIGURE 52
MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
FIGURE 53
DATA TRIANGULATION METHODOLOGY
Growth opportunities and latent adjacency in Radiotherapy Market